INTERMUNE INC (ITMN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
3280 BAYSHORE, BLVD, BRISBANE, CA 94005
415 466 2200

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 6.537 Billion Shares Outstanding88.47 Million Avg 30-day Volume 3.52 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.31
Price to Revenue42.7818 Debt to Equity0.6895 EBITDA-202.123 Million
Price to Book Value14.0182 Operating Margin-188.8828 Enterprise Value4.441 Billion
Current Ratio6.994 EPS Growth0.108 Quick Ratio6.74
1 Yr BETA 2.0517 52-week High/Low 0.0 / Profit Margin-207.915
Operating Cash Flow Growth-1.091 Altman Z-Score6.3365 Free Cash Flow to Firm -146.407 Million
View SEC Filings from ITMN instead.

View recent insider trading info

Funds Holding ITMN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ITMN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KABAKOFF DAVID S

  • Director
No longer subject to file 2014-09-29 0

WELCH DANIEL G CHAIRMAN, CEO AND PRESIDENT

  • Officer
  • Director
No longer subject to file 2014-09-29 0

HODGMAN JOHN EVP, FINANCE & CFO

  • Officer
No longer subject to file 2014-09-29 0

BIENAIME JEAN JACQUES

  • Director
No longer subject to file 2014-09-29 0

HEALY JAMES

  • Director
No longer subject to file 2014-09-29 0

DRAPEAU LOUIS

  • Director
No longer subject to file 2014-09-29 0

EKMAN LARS

  • Director
No longer subject to file 2014-09-29 0

ARATA PAUL D EVP, HUMAN RESOURCES & ADMIN

  • Officer
No longer subject to file 2014-09-29 0

LEFF JONATHAN A EVP, RESEARCH & DEVELOPMENT

  • Officer
No longer subject to file 2014-09-29 0

DI NEPI GIACOMO EVP MANAGING DIRECTOR, EUROPE

  • Officer
No longer subject to file 2014-09-29 0

RUSSELL ANGUS C.

  • Director
No longer subject to file 2014-09-29 0

VERWIEL FRANK

  • Director
No longer subject to file 2014-09-29 0

NOLAN SEAN P. EVP & CBO

  • Officer
No longer subject to file 2014-09-29 0

POWELL ANDREW KENNETH WILLIAM EVP, GC & SECRETARY

  • Officer
30,250 2014-09-15 0

STEELE ROBIN JOAN SVP, GC, SECRETARY

  • Officer
31,890 2013-06-05 0

LEFF JONATHAN S

  • Director
77,251 2013-02-28 0

ARMSTRONG PORTER MARIANNE SVP CH REG & DRUG SAFETY OFF

  • Officer
37,762 2012-05-11 0

PORTER STEVEN BRYANT CHIEF MEDICAL OFFICER

  • Officer
37,762 2012-05-11 0

BRADFORD WILLIAMSON Z III SVP-CLINICAL SCIENCE

  • Officer
56,392 2012-05-11 0

SEIWERT SCOTT SVP, RSEARCH & TECHNICAL DEV.

  • Officer
39,669 2012-05-11 0

COHEN ALAN HOWARD SVP, MEDICAL AFFAIRS

  • Officer
16,518 2012-05-11 0

SIMON HOWARD ALLAN SVP-HUMAN RESOURCES

  • Officer
20,957 2011-12-09 0

WARBURG PINCUS EQUITY PARTNERS LP

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH

  • Director
  • 10% Owner
No longer subject to file 2011-05-11 0

RINGO WILLIAM R

  • FORMER DIRECTOR
0 2008-07-23 0

BLATT LAWRENCE

  • FRMR CHIEF SCIENTIFIC OFFICER
7,083 2008-05-19 0

KASSBERG THOMAS RICHARD

  • FORMER SVP-COR.DEV.COM. OPER.
0 2007-10-15 0

ROBINSON CYNTHIA Y

  • FORMER SVP-DEV. OPERATIONS
4,414 2007-10-01 0

SMITH MICHAEL L

  • Director
117,002 2007-05-15 0

HALLEEN NORMAN

  • FORMER SVP-FINANCE & CFO
0 2006-12-18 0

HALTER WILLIAM A

  • FORMER DIRECTOR
0 2006-12-08 0

HAWLEY ROGER

  • FORMER EVP-COMM. & TECH. OPER.
0 2006-03-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments